PC plasmalogen-A, C38:7 PC plasmalogen, C36:1 PC plasmalogen, C36:2 PC plasmalogen, C36:3 PC plasmalogen, C38:4 PC plasmalogen, C40:7 PC plasmalogen, C36:4 PC plasmalogen Lysophosphatidylethanolamie (PE) C34:0 PE, C34:2 PE, C36:4 PE, C38:2 PE, C34:2 PE plasmalogen, C36:0 PE, C36:1 PE, C36:2 PE, C38:4 PE, C40:6 PE, C36:3 PE, C38:5 PE, C36:2 PE plasmalogen, C38:6 PE, C34:3 PE plasmalogen, C38:3 PE plasmalogen, C38:5 PE plasmalogen, C38:6 PE plasmalogen, C40:7 PE plasmalogen, C36:5 PE plasmalogen, C38:7 PE plasmalogen, C36:3 PE plasmalogen, C36:4 PE plasmalogen Sphingomyeline (SM) C18:0 SM, C16:0 SM, C24:0 SM, C14:0 SM, C20:0 SM, C22:0 SM, C22:1 SM Triacylglycerol (TAG)   C48:0 TAG, C50:0 TAG, C48:1 TAG, C50:1 TAG, C52:4 TAG, C52:0 TAG, C52:1 TAG, C52:2 TAG,  C54:4 TAG, C48:2 TAG, C50:2 TAG, C52:3 TAG, C54:5 TAG, C56:8 TAG, C54:1 TAG, C54:2 TAG,  C56:2 TAG, C54:3 TAG, C56:5 TAG, C56:3 TAG, C58:8 TAG, C48:3 TAG, C50:3 TAG, C50:4 TAG,  C52:6 TAG, C56:9 TAG, C56:6 TAG, C56:7 TAG, C58:9 TAG, C58:7 TAG, C60:12 TAG, C46:0 TAG,  C46:1 TAG, C46:2 TAG, C50:5 TAG, C50:6 TAG, C54:9 TAG, C56:10 TAG, C52:7 TAG, C54:8 TAG,  C58: Figure S1 . Flow chart of current study.
NHS started in 1976
121,700 female nurses completed an initial questionnaire; Blood samples were collected from 32,826 participants during [1989] [1990] .
NHSII started in 1989
116,429 female nurses completed an initial questionnaire; Blood samples were collected from 29,611 participants during 1996-1999.
HPFS started in 1986
51,529 male health professionals completed an initial questionnaire; Blood samples were collected from 18,225 participants during 1993-1995.
All participants were followed up by questionnaires every two years; Free of cardiovascular disease at the time of blood draw; We selected self-reported VTE or PE, and sampled their controls; 
